Nabel GJ - Search Results

1

Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice.

Moore AC, Kong WP, Chakrabarti BK, Nabel GJ. Moore AC, et al. Among authors: nabel gj. J Virol. 2002 Jan;76(1):243-50. doi: 10.1128/jvi.76.1.243-250.2002. J Virol. 2002. PMID: 11739689 Free PMC article.

2

Activation of the human immunodeficiency virus type 1 enhancer is not dependent on NFAT-1.

Markovitz DM, Hannibal MC, Smith MJ, Cossman R, Nabel GJ. Markovitz DM, et al. Among authors: nabel gj. J Virol. 1992 Jun;66(6):3961-5. doi: 10.1128/JVI.66.6.3961-3965.1992. J Virol. 1992. PMID: 1533884 Free PMC article.

3

Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection.

Butera ST, Perez VL, Wu BY, Nabel GJ, Folks TM. Butera ST, et al. Among authors: nabel gj. J Virol. 1991 Sep;65(9):4645-53. doi: 10.1128/JVI.65.9.4645-4653.1991. J Virol. 1991. PMID: 1678437 Free PMC article.

4

Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma.

Foreman KE, Friborg J Jr, Kong WP, Woffendin C, Polverini PJ, Nickoloff BJ, Nabel GJ. Foreman KE, et al. Among authors: nabel gj. N Engl J Med. 1997 Jan 16;336(3):163-71. doi: 10.1056/NEJM199701163360302. N Engl J Med. 1997. PMID: 8988896 Free article.

5

Cell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory gene.

Ranga U, Woffendin C, Yang ZY, Xu L, Verma S, Littman DR, Nabel GJ. Ranga U, et al. Among authors: nabel gj. J Virol. 1997 Sep;71(9):7020-9. doi: 10.1128/JVI.71.9.7020-7029.1997. J Virol. 1997. PMID: 9261432 Free PMC article.

6

Distinct biology of Kaposi's sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas.

Friborg J Jr, Kong WP, Flowers CC, Flowers SL, Sun Y, Foreman KE, Nickoloff BJ, Nabel GJ. Friborg J Jr, et al. Among authors: nabel gj. J Virol. 1998 Dec;72(12):10073-82. doi: 10.1128/JVI.72.12.10073-10082.1998. J Virol. 1998. PMID: 9811747 Free PMC article.

7

p53 inhibition by the LANA protein of KSHV protects against cell death.

Friborg J Jr, Kong W, Hottiger MO, Nabel GJ. Friborg J Jr, et al. Among authors: nabel gj. Nature. 1999 Dec 23-30;402(6764):889-94. doi: 10.1038/47266. Nature. 1999. PMID: 10622254

8

Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression.

Huang Y, Kong WP, Nabel GJ. Huang Y, et al. Among authors: nabel gj. J Virol. 2001 May;75(10):4947-51. doi: 10.1128/JVI.75.10.4947-4951.2001. J Virol. 2001. PMID: 11312370 Free PMC article.

9

Vaccines for the prevention of HIV-1 disease.

Mascola JR, Nabel GJ. Mascola JR, et al. Among authors: nabel gj. Curr Opin Immunol. 2001 Aug;13(4):489-95. doi: 10.1016/s0952-7915(00)00246-6. Curr Opin Immunol. 2001. PMID: 11498307 Review.

10

Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.

Chakrabarti BK, Kong WP, Wu BY, Yang ZY, Friborg J, Ling X, King SR, Montefiori DC, Nabel GJ. Chakrabarti BK, et al. Among authors: nabel gj. J Virol. 2002 Jun;76(11):5357-68. doi: 10.1128/jvi.76.11.5357-5368.2002. J Virol. 2002. PMID: 11991964 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

447 results

Search Page

Filters